Avery Healthcare Holdings Limited in Northampton, NN4 9BS

Description

Data updated on: 01-11-2023

Avery Healthcare Holdings came into being in 2016 as a company enlisted under no 10513243, located at NN4 9BS Northampton at 3 Cygnet Drive. This company has been in business for 8 years and its state is active. The enterprise's SIC and NACE codes are 70100 and their NACE code stands for Activities of head offices. Avery Healthcare Holdings Ltd filed its latest accounts for the period that ended on 2022-03-31. The firm's latest confirmation statement was released on 2023-04-28.

The limited company owes its accomplishments and permanent growth to exactly four directors, who are Sebastian B., Carl C., David R. and John S., who have been in it since January 2023. What is more, the managing director's assignments are constantly supported by a secretary - Richard C., who was officially appointed by this limited company one year ago.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2021-03-31	2022-03-31	2023-03-31
Currency

Balance Sheet
Cash Bank On Hand	2 657	140 613	15 792
Current Assets	3 166 646	18 111 314	16 465 299
Debtors	3 163 989	17 970 701	16 449 507
Net Assets Liabilities	41 953 108	41 536 003	39 187 883
Other Debtors	4 691	4 691	42 244
Property Plant Equipment	12 095	7 329	2 562
Total Inventories	833 823	311 738

Other Financial Data
Accrued Liabilities Deferred Income	91 311 125	94 419 664	96 672 300
Accumulated Amortisation Impairment Intangible Assets	10 206 420	12 221 113	14 343 323
Accumulated Depreciation Impairment Property Plant Equipment	562 903	643 581	378 978
Additions Other Than Through Business Combinations Property Plant Equipment		110 314	18 711
Administrative Expenses	92 750 517	111 478 111	106 876 551
Amounts Owed To Group Undertakings	10 596 056	485 011	1 302 782
Bank Borrowings	20 750 000
Bank Borrowings Overdrafts	20 750 000
Cash Cash Equivalents	2 657	17 120 077	10 204 576
Cash Cash Equivalents Cash Flow Value	2 657	140 613	15 792
Comprehensive Income Expense	-10 676 370	-12 885 358	-10 149 056
Corporation Tax Payable			605 912
Corporation Tax Recoverable	17 512	17 512	17 512
Cost Sales	77 891 541	95 392 344	106 361 902
Creditors	10 602 627	829 551	1 526 889
Deferred Tax Asset Debtors	746	1 452	1 087 076
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences		1 102 358	-260 458
Dividends Paid Classified As Financing Activities	-1 900 000
Dividends Paid To Owners Parent Classified As Financing Activities	-1 900 000
Dividends Received Classified As Investing Activities	-2 300 000
Finance Lease Liabilities Present Value Total	118 632	83 952	35 203
Finance Lease Payments Owing Minimum Gross	72 006	90 419	88 635
Fixed Assets	49 389 089	49 104 207	49 099 440
Foreign Exchange Differences Increase Decrease In Depreciation Impairment Property Plant Equipment		-75 853
Further Item Deferred Expense Credit Component Total Deferred Tax Expense		116 749	400 112
Further Item Operating Expense Loss Income Statement Item Component Operating Profit Loss	164 980
Further Item Tax Increase Decrease Component Adjusting Items	-57	958 446	318 763
Future Finance Charges On Finance Leases		59 686	37 448
Gain Loss On Disposals Property Plant Equipment	-164 980	11 713
Government Grant Income	2 227 005	9 812 483
Impairment Loss Reversal On Investments		-3 630 120
Increase Decrease From Foreign Exchange Differences Property Plant Equipment		-436 473	-32 786 653
Increase Decrease In Current Tax From Adjustment For Prior Periods		116 749	400 112
Increase From Amortisation Charge For Year Intangible Assets		2 014 693	2 122 210
Increase From Depreciation Charge For Year Property Plant Equipment		80 678	74 921
Intangible Assets	28 540 563	26 525 870	24 403 660
Intangible Assets Gross Cost	38 746 983	38 746 983
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings	4 070 627	5 547 644
Interest Expense On Obligations Under Finance Leases Hire Purchase Contracts	52 752	48 565
Interest Income On Bank Deposits	155	913	271
Interest Paid Classified As Operating Activities	-4 123 379	-124 273	-2 102 819
Interest Payable Similar Charges Finance Costs	4 123 379	124 273	2 102 819
Interest Received Classified As Investing Activities		-913	-271
Investments Fixed Assets	49 376 994	49 096 878	49 096 878
Investments In Subsidiaries	49 376 994	49 096 878	49 096 878
Net Finance Income Costs	2 300 000	913	271
Other Creditors	27 705 448	24 136 077	19 477 616
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment		597 713	339 524
Other Disposals Property Plant Equipment		1 828 295	388 699
Other Interest Receivable Similar Income Finance Income	155	913	271
Other Remaining Borrowings	35 744 990	24 849 967	24 849 967
Pension Other Post-employment Benefit Costs Other Pension Costs	1 197 811	1 188 695	1 238 374
Percentage Class Share Held In Subsidiary		90
Prepayments Accrued Income	27 666	3 753 724	15 277 143
Profit Loss	1 955 850	-417 105	-2 348 120
Property Plant Equipment Gross Cost	753 911	864 225	494 237
Raw Materials Consumables	305 026	311 738
Social Security Costs	5 446 598	5 555 479
Staff Costs Employee Benefits Expense	81 212 201	86 409 846	97 322 898
Taxation Including Deferred Taxation Balance Sheet Subtotal		1 219 108
Tax Decrease Increase From Effect Revenue Exempt From Taxation	5 863
Tax Increase Decrease Arising From Group Relief Tax Reconciliation		245 459	248 970
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss	1 073 860	1 012 200	3 453 084
Tax Tax Credit On Profit Or Loss On Ordinary Activities	50 672	-706	-600
Total Borrowings	38 864 569	24 849 967	24 849 967
Total Deferred Tax Expense Credit		1 219 107	139 654
Trade Creditors Trade Payables	6 571	120 267	10 891 707
Trade Debtors Trade Receivables	7 542 909	8 249 923	8 269 290
Transfers To From Non-current Assets Or Disposal Groups Held For Sale Property Plant Equipment		2 342 817
Transfer To Non-current Assets Or Disposal Groups Held For Sale Decrease In Depreciation Impairment Property Plant Equipment		1 845 407
Turnover Revenue	171 811 167	170 337 994
Wages Salaries	74 567 792	79 665 672	89 927 891

Company staff

Richard C.

Role: Secretary

Appointed: 11 May 2023

Latest update: 1 March 2024

Sebastian B.

Role: Director

Appointed: 27 January 2023

Latest update: 1 March 2024

Carl C.

Role: Director

Appointed: 09 March 2022

Latest update: 1 March 2024

David R.

Role: Director

Appointed: 09 March 2022

Latest update: 1 March 2024

John S.

Role: Director

Appointed: 06 December 2016

Latest update: 1 March 2024

Daniel G.

Role: Director

Appointed: 10 March 2022

Resigned: 27 January 2023

Latest update: 1 March 2024

John G.

Role: Director

Appointed: 20 December 2016

Resigned: 21 December 2016

Latest update: 1 March 2024

Ian M.

Role: Director

Appointed: 06 December 2016

Resigned: 09 March 2022

Latest update: 1 March 2024

Matthew P.

Role: Secretary

Appointed: 06 December 2016

Resigned: 28 April 2023

Latest update: 1 March 2024

Matthew P.

Role: Director

Appointed: 06 December 2016

Resigned: 28 April 2023

Latest update: 1 March 2024

People with significant control

The companies with significant control over this firm are: Veilchenblau Estates Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in London at Millbank Tower, 21-24 Millbank, SW1P 4QP and was registered as a PSC under the reg no 12057915.

Veilchenblau Estates Limited

Address: 4th Floor Millbank Tower, 21-24 Millbank, London, SW1P 4QP, England

Legal authority Companies Act 2006

Legal form Private Limited Company

Country registered England

Place registered Companies House

Registration number 12057915

Notified on 9 March 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Xanadu Investments Limited

Address: Keepers Lodge Hollowell, Northampton, Northamptonshire, NN6 8RL, United Kingdom

Legal authority Uk Law

Legal form Company Limited By Shares

Country registered England

Place registered England & Wales

Registration number 07461407

Notified on 4 April 2017

Ceased on 9 March 2022

Nature of control:

over 1/2 to 3/4 of shares

over 1/2 to 3/4 of voting rights

right to manage directors

John S.

Notified on 6 December 2016

Ceased on 4 April 2017

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	12 May 2024
Confirmation statement last made up date	28 April 2023

Annual Accounts
Start Date For Period Covered By Report	2021-04-01
End Date For Period Covered By Report	2022-03-31
Annual Accounts
Start Date For Period Covered By Report	2022-04-01
End Date For Period Covered By Report	2023-03-31

Avery Healthcare Holdings Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Richard C.

Sebastian B.

Carl C.

David R.

John S.

Daniel G.

John G.

Ian M.

Matthew P.

Matthew P.

People with significant control

Veilchenblau Estates Limited

Xanadu Investments Limited

John S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies